Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment.


Buduneli N. G. , Buduneli E. , Kuetuekcueler N.

Journal of periodontology, vol.80, no.8, pp.1274-80, 2009 (Journal Indexed in SCI Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 80 Issue: 8
  • Publication Date: 2009
  • Doi Number: 10.1902/jop.2009.090106
  • Title of Journal : Journal of periodontology
  • Page Numbers: pp.1274-80
  • Keywords: Chronic periodontitis, gingival crevicular fluid, interleukin-17, osteoprotegerin, receptor activator of nuclear factor-kappa B ligand, smoking, KAPPA-B LIGAND, NECROSIS-FACTOR RECEPTOR, OSTEOCLAST DIFFERENTIATION, CIGARETTE-SMOKING, RISK INDICATORS, ACTIVATOR, DISEASE, THERAPY, INFLAMMATION, CYTOKINE

Abstract

Background: This study was performed to evaluate the effects of initial periodontal treatment on the gingival crevicular fluid (GCF) levels of interleukin (IL)-17, soluble receptor activator of nuclear factor-kappa B ligand (sRANKL), and osteoprotegerin (OPG) in smoking and non-smoking patients with chronic periodontitis.